scholarly article | Q13442814 |
P50 | author | H Jurgen Schelhaas | Q114416529 |
P2093 | author name string | Pieter A van Doorn | |
Harro Seelaar | |||
John C van Swieten | |||
Patrizia Rizzu | |||
Wouter Kamphorst | |||
Rob Willemsen | |||
Benno Küsters | |||
Danielle Majoor-Krakauer | |||
Asma Azmani | |||
Maarten C de Rijk | |||
Ming ten Brummelhuis | |||
Sonia Rosso | |||
P433 | issue | Pt 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | frontotemporal dementia | Q18592 |
dementia | Q83030 | ||
motor neuron disease | Q3221083 | ||
pathology | Q7208 | ||
P304 | page(s) | 1375-1385 | |
P577 | publication date | 2007-03-14 | |
P1433 | published in | Brain | Q897386 |
P1476 | title | TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations | |
P478 | volume | 130 |
Q36165139 | A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes |
Q50350613 | Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies. |
Q48265074 | Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion. |
Q47548699 | CXorf56, a dendritic neuronal protein, identified as a new candidate gene for X-linked intellectual disability. |
Q38118236 | Clinical Subtypes of Frontotemporal Dementia |
Q38109705 | Co-localization of Bunina bodies and TDP-43 inclusions in lower motor neurons in amyotrophic lateral sclerosis |
Q26863439 | Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis |
Q38262690 | Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. |
Q35776901 | Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations |
Q36741538 | Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation |
Q37241079 | FTD and ALS: a tale of two diseases |
Q33922335 | FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration |
Q36417318 | Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p |
Q37461525 | Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy. |
Q38392876 | Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations |
Q33830991 | Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration |
Q38005607 | Frontotemporal dementia as a frontostriatal disorder: neostriatal morphology as a biomarker and structural basis for an endophenotype. |
Q48094135 | Hippocampal sclerosis in the parkinsonism-dementia complex of Guam: quantitative examination of neurons, neurofibrillary tangles, and TDP-43 immunoreactivity in CA1. |
Q51973117 | Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. |
Q33828911 | Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons |
Q37260852 | Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia |
Q35592875 | On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia |
Q37918720 | RNA-binding proteins with prion-like domains in ALS and FTLD-U. |
Q24648173 | Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability |
Q34642738 | Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration |
Q35512201 | Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration |
Q33896030 | Survival profiles of patients with frontotemporal dementia and motor neuron disease |
Q39138644 | Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies. |
Q41514570 | TAR DNA-binding protein-43 in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and Alzheimer disease |
Q24594172 | TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43 |
Q37733168 | TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration |
Q28261458 | TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor |
Q37183193 | TDP-43: a novel neurodegenerative proteinopathy |
Q89497713 | The Role of RNA Binding Proteins for Local mRNA Translation: Implications in Neurological Disorders |
Q39657178 | The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. |
Q24615201 | The genetics and neuropathology of frontotemporal lobar degeneration |
Q36926070 | The genetics of frontotemporal lobar degeneration |
Q36485513 | The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum |
Q30495415 | The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration |
Q37064056 | The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases |
Q42461104 | Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease |
Q33548806 | Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. |
Q41878973 | Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices |
Q37205729 | Update on recent molecular and genetic advances in frontotemporal lobar degeneration |
Q33511759 | Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. |
Search more.